Gain Therapeutics Bolsters Management Team with the
BETHESDA, Md., April 08, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology...
Source: globenewswire.com
Stay updated with breaking news from Lazard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BETHESDA, Md., April 08, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology...
Utility industry news and analysis for energy professionals.
JPMorgan Chase is preparing for the day when Jamie Dimon is no longer head of banking behemoth.
Queensland Investment Corp is expected to provide management services to Australia’s $272 billion sovereign wealth fund.
Macrotech Developers' net debt stood at Rs 3,010 crore as of March 31, 2024, down 55 per cent from the previous quarter, according to a regulatory filing.